CPT Pharmacometrics Syst Pharmacol
Antineoplastic Combined Chemotherapy ProtocolsCarboplatinNeutrophils
Dr. Michael L. Maitland, MD, PhD
NPI1003851460
- Medicare services, 2020
- 93
- Part D claims, 2022
- 11
- Publications
- 61
- Clinical trials
- 8
- Hospital affiliations
- 1
- Practice address
- 3300 Gallows Road, Falls Church, VA 22042
- Practice phone
- Call (703) 698-1110
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Maitland's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael L. Maitland is a medical oncologist in Falls Church, Virginia
Dr. Maitland practices at Inova Fairfax Hospital in Falls Church, Virginia, part of Inova Health Care Services.
Dr. Maitland's NPI, 1003851460, was assigned on June 19, 2006. Dr. Maitland graduated from Albert Einstein College of Medicine of Yeshiva University in 2000. Dr. Maitland holds Virginia license 0101261271.
NPI and contact details
- NPI
- 1003851460NPI Registry (opens in a new tab)
- NPI enumeration date
- June 19, 2006
- NPI status
- Active
- Practice phone
- (703) 698-1110
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Michael L. Maitland practices at Inova Fairfax Hospital in Falls Church, Virginia
Dr. Maitland's primary practice is Inova Fairfax Hospital, at 3300 Gallows Road, Falls Church, VA 22042 in Fairfax County. The practice phone is (703) 698-1110.
- Inova Fairfax Hospital3300 Gallows Road, Falls Church, VA 22042 · Fairfax CountyPhone(703) 698-1110
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Michael L. Maitland is affiliated with 1 site of care and 1 medical group
Dr. Maitland's primary practice is Inova Fairfax Hospital in Falls Church, Virginia, part of Inova Health Care Services. The medical group on file is Inova Urgent Care Center.
Sources: Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael L. Maitland's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maitland practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Inova Fairfax Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Maitland practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Inova Health Care Services and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael L. Maitland is one of 99 medical oncologists in Virginia
Medical oncology is Dr. Maitland's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Maitland's licenses on file in 2 states: Virginia and Illinois.
Specialties and state licenses
- Medical oncology, VirginiaPrimary
- Clinical pharmacology, Illinois
Medical oncologists near Dr. Maitland
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
99medical oncologists in Virginia21medical oncologists in Falls Church2medical oncologists at Inova Fairfax Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael L. Maitland billed Medicare for 93 services in 2020
CMS data shows 93 Medicare services from Dr. Maitland across 2 procedure codes in 2020, all of them office visits. Medicare paid $7,993 for them. Every service was in an office.
Medicare services, 202093
Paid by Medicare$7,993
Procedure codes2
Dr. Maitland's Medicare services by type, 2019 to 2020
- 2019
- 2020
- Office and hospital visits
- 2019: 2682020: 9365%
Dr. Maitland compared with the Virginia median for medical oncologists, 2020
- Dr. Maitland
- Virginia median
- Medicare services
- 93vs 56684% below
- Part D claims
- 11vs 30396% below
Medians across 96 medical oncologists in Virginia with Dmand AI profiles that report each measure.
Dr. Maitland's most billed Medicare procedure codes, 2020
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Maitland?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Maitland and other medical oncologists in Virginia.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Michael L. Maitland's patients have a median age of 38
Across all payers, Dmand AI patient panel data puts Dr. Maitland's median patient age at 38, with 67% women.
Dr. Maitland's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 38
Patient panel by sex, all payers
- Women67%
- Men33%
Source: Dmand AI Patient Panel Data
Dr. Michael L. Maitland wrote 11 Medicare Part D claims in 2022
In 2022, Dr. Maitland wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $41 in total drug cost. In 2016, CMS named 14 claims across 1 drug.
Part D claims, 202211
Drugs named by CMS1
Total drug cost$41
Dr. Maitland's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2016 to 2022
- 2016
- 2022
- Claims for drugs CMS names
- 2016: 142022: 1121%
Drugs named by CMS: 1 in 2022, 1 in 2016.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find medical oncologists like Dr. Maitland by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael L. Maitland has 61 publications on record
Dmand AI links 61 papers to Dr. Maitland, published from 2006 to 2024. 2015 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents and Phenylurea Compounds. Dr. Maitland has published most often in Clin Cancer Res. Dr. Maitland's most frequent co-authors are Lawrence H. Schwartz, MD, Geoffrey R. Oxnard, MD and Matthew R. Levine, MD.
Papers61
Years published2006 to 2024
Dr. Maitland's papers by year, 2015 to 2024
Topics Dr. Maitland writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- Phenylurea Compounds
- Niacinamide
- Sorafenib
- Clinical Trials, Phase III as Topic
- Lung Neoplasms
- Tomography, X-Ray Computed
Dr. Maitland's most frequent co-authors
- Lawrence H. Schwartz, MD8 shared papers
- Geoffrey R. Oxnard, MD5 shared papers
- Matthew R. Levine, MD4 shared papers
Recent publications by Dr. Maitland
AdipocytesAdipose Tissue, BrownAngiopoietin-2
Pharmacogenet Genomics
Antihypertensive AgentsEpoprostenolFamilial Primary Pulmonary Hypertension
See who Dr. Maitland researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Maitland works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael L. Maitland has worked on 8 clinical trials
Dmand AI links Dr. Maitland to 8 clinical trials, 3 of them phase 3 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Carcinoma, Endometrioid. National Cancer Institute (NCI) sponsors the most, 5.
Clinical trials with Dr. Maitland by phase
- 1Phase 1: 1 trial
- 1Phase 2: 1 trial
- 2Phase 2/3: 2 trials
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Maitland's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Carcinoma, Endometrioid
- Fallopian Tube Diseases
- Endometrial Neoplasms
Investigators on the most trials with Dr. Maitland
Recent clinical trials with Dr. Maitland
Vorinostat and Carboplatin or Vorinostat and Paclitaxel in Patients With Advanced Solid Tumors: A Pharmacokinetic and Pharmacodynamic Study (opens in a new tab)
Active, not recruitingPhase 1
CarboplatinPaclitaxelVorinostat
Carcinoma, EndometrioidEndometrial NeoplasmsCopanlisib
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (opens in a new tab)
Active, not recruitingPhase 2/3
Fallopian Tube DiseasesFallopian Tube NeoplasmsAtezolizumabBevacizumabPegylated Liposomal Doxorubicin Hydrochloride
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (opens in a new tab)
Active, not recruitingPhase 3
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicNivolumab
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicCrizotinib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael L. Maitland received $871 in industry payments from 2017 to 2024
CMS Open Payments shows 5 general payments to Dr. Maitland from 2 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 75% of the total. Pfizer Inc. paid the most, $825. It also lists 4 research payments totaling $7,670 from 2020 to 2023.
General payments to Dr. Maitland by program year, 2017 to 2024
General payments to Dr. Maitland by kind, 2017 to 2024
$871in total
- Travel and lodging$65775%
- Food and beverage$21224%
- Education$10%
Companies that paid Dr. Maitland the most, 2017 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael L. Maitland graduated from Albert Einstein College of Medicine of Yeshiva University
Dr. Maitland graduated from Albert Einstein College of Medicine of Yeshiva University in 2000.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Michael L. Maitland's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael L. Maitland
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael L. Maitland's NPI number?
Dr. Michael L. Maitland's NPI number is 1003851460. It was assigned on June 19, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael L. Maitland?
Dr. Michael L. Maitland is a medical oncologist in Falls Church, Virginia. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Michael L. Maitland practice?
Dr. Maitland practices at 3300 Gallows Road, Falls Church, VA 22042. Dr. Maitland's primary practice is Inova Fairfax Hospital in Falls Church, Virginia, part of Inova Health Care Services.
What is Dr. Michael L. Maitland's office phone number?
The practice phone on file for Dr. Maitland is (703) 698-1110.
What is Dr. Michael L. Maitland's medical license number?
Dr. Maitland holds Virginia license 0101261271, one of the licenses on file in 2 states.
Which states has Dr. Michael L. Maitland been licensed in?
Dmand AI has state licenses on file for Dr. Maitland in Virginia and Illinois.
Which hospitals is Dr. Michael L. Maitland affiliated with?
Dr. Maitland practices at Inova Fairfax Hospital in Falls Church, Virginia.
What medical group is Dr. Michael L. Maitland part of?
Dr. Maitland is linked to Inova Urgent Care Center.
Does Dr. Michael L. Maitland accept Medicare?
Yes. CMS data shows Dr. Maitland billed Medicare for 93 services in 2020.
What services does Dr. Michael L. Maitland bill to Medicare?
In 2020, Dr. Maitland's most billed Medicare services were office visit, established patient (99215) and office visit, established patient (99214).
Show 6 more questionsShow fewer questions
Where did Dr. Michael L. Maitland go to medical school?
Dr. Maitland graduated from Albert Einstein College of Medicine of Yeshiva University in 2000.
What drugs does Dr. Michael L. Maitland prescribe most?
In 2022 Medicare Part D data, Dr. Maitland's most prescribed drugs by claims were Mirtazapine.
Has Dr. Michael L. Maitland received payments from drug or device companies?
CMS Open Payments shows $871 in general payments to Dr. Maitland from 2 companies from 2017 to 2024. The largest total came from Pfizer Inc.
How long has Dr. Michael L. Maitland been practicing?
Dr. Maitland graduated from medical school in 2000, 26 years ago.
Does Dr. Michael L. Maitland do research?
Dmand AI links 61 publications to Dr. Maitland, published from 2006 to 2024. Dr. Maitland has worked on 8 clinical trials.
Who does Dr. Michael L. Maitland publish with?
Dr. Maitland's most frequent co-authors are Lawrence H. Schwartz, MD (8 shared papers), Geoffrey R. Oxnard, MD (5 shared papers) and Matthew R. Levine, MD (4 shared papers).
Selling to medical oncology practices?
See medical oncologists in Virginia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card